FDMT logo

4D Molecular Therapeutics, Inc. (FDMT)

Profile

Full Name

4D Molecular Therapeutics, Inc.

Ticker

NASDAQ: FDMT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 11, 2020

Indexes

Not included

Website

https://www.4dmoleculartherapeutics.com

Employees

227

Key Details

Price

$10.70(-4.38%)

Market Cap

$611.35M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$37.00K(-99.82% YoY)

Annual EPS

-$2.98(-15.72% YoY)

PE Ratio

-

Next earnings date

Feb 27, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.70
    FDMT price is $10.70

    30-Day Relative Volume

    0.51
    FDMT 30-day relative volume is 0.51

    Price Performance

    Price Most Recent Change

    -4.38%
    FDMT price was down -4.38% on Dec 5, 2025

    Price YTD Change

    +92.1%
    FDMT price is up +92.1% since January 1st

    Price 1-Year Change

    +56.89%
    FDMT price is up +56.89% year-on-year

    Price 3-Year Change

    -53.82%
    FDMT price is down -53.82% over the past 3 years

    Price Range

    Price All-Time High

    $55.11
    FDMT price is currently -80.58% below its historical high of $55.11

    Price 3-Year Low

    $2.23
    FDMT price is currently +378.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $611.35M
    FDMT market cap is $611.35 million

    Market Cap 3-Year Change

    -18.55%
    FDMT market cap is down -18.55% over the past 3 years

    Market Cap All-Time High

    $1.79B
    FDMT market cap is currently -65.76% below its historical high of $1.79 billion

    Market Cap Sector Percentile

    64.37%
    FDMT market cap is higher than 64.37% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +23.59%
    FDMT shares outstanding is up +23.59% year-on-year

    Shares Outstanding 3-Year Change

    +76.38%
    FDMT shares outstanding is up +76.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.26
    FDMT beta is 1.26

    200-day SMA

    $6.00
    FDMT price is currently +78.23% above its 200-day simple moving average

    50-day SMA

    $10.32
    FDMT price is currently +3.69% above its 50-day simple moving average

    14-Day RSI

    50.61
    FDMT 14-day relative strength index is 50.61

    Volume

    0.51
    FDMT 30-day relative volume is 0.51

    ATR

    $0.84
    FDMT average true range is $0.84

    10-day Historical Volatility

    84.16%
    FDMT 10-day historical volatility is 84.16%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $37.00K
    FDMT annual revenue is $37.00 thousand

    Revenue Analysts Estimate

    $37.74M
    FDMT annual revenue is currently -99.90% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -99.82%
    FDMT annual revenue is down -99.82% year-on-year

    Revenue Sector Percentile

    29.94%
    FDMT annual revenue is higher than 29.94% of companies in Healthcare sector

    EPS

    EPS

    -$2.98
    FDMT annual earnings per share is -$2.98

    EPS Analysts Estimate

    -$3.26
    FDMT annual earnings per share is currently +8.49% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -15.72%
    FDMT annual earnings per share is down -15.72% year-on-year

    EPS Sector Percentile

    30.84%
    FDMT annual earnings per share is higher than 30.84% of companies in Healthcare sector

    Profit

    Gross Profit

    -$6.67M
    FDMT annual gross profit is -$6.67 million

    Gross Margin

    -18.02K%
    FDMT annual gross profit margin is -18.02 thousand%

    Operating Profit

    -$187.84M
    FDMT annual operating income is -$187.84 million

    Operating Margin

    -507.68K%
    FDMT annual operating profit margin is -507.68 thousand%

    Net Income

    -$160.87M
    FDMT annual net profit is -$160.87 million

    Net Margin

    -434.78K%
    FDMT annual net profit margin is -434.78 thousand%

    Expenses

    Total Expenses

    $187.88M
    FDMT annual total expenses is $187.88 million

    Operating Expenses

    $187.88M
    FDMT annual total operating expenses is $187.88 million

    Cost Of Goods Sold

    $6.71M
    FDMT annual cost of goods sold is $6.71 million

    Selling, General & Administrative Expenses

    $46.58M
    FDMT annual SG&A is $46.58 million

    Depreciation & Amortization

    $6.71M
    FDMT annual D&A is $6.71 million

    Interest Expense

    $0.00
    FDMT annual interest expense is $0.00

    Income Tax

    $0.00
    FDMT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$187.84M
    FDMT annual earnings before interest & taxes is -$187.84 million

    EBITDA

    -$181.14M
    FDMT annual EBITDA is -$181.14 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $560.38M
    FDMT annual total assets is $560.38 million

    Non Current Assets

    $125.45M
    FDMT annual long term assets is $125.45 million

    Current Assets

    $434.93M
    FDMT annual total current assets is $434.93 million

    Cash and Cash Equivalents

    $149.34M
    FDMT annual cash & cash equivalents is $149.34 million

    Accounts Receivable

    -
    FDMT annual accounts receivable value is unknown

    Inventory

    $0.00
    FDMT annual inventory is $0.00

    Liabilities

    Total Liabilities

    $49.78M
    FDMT annual total liabilities is $49.78 million

    Long Term Liabilities

    $20.63M
    FDMT annual total long term liabilities is $20.63 million

    Current Liabilities

    $29.15M
    FDMT annual current liabilities is $29.15 million

    Accounts Payable

    $4.39M
    FDMT annual accounts payable is $4.39 million

    Debt

    Total Debt

    $24.61M
    FDMT annual total debt is $24.61 million

    Total Debt 1-Year Change

    +67.72%
    FDMT annual total debt is up +67.72% year-on-year

    Long Term Debt

    $18.97M
    FDMT annual long term debt is $18.97 million

    Short Term Debt

    $5.64M
    FDMT annual short term debt is $5.64 million

    Equity & Capital

    Shareholders Equity

    $510.61M
    FDMT annual stockholders equity is $510.61 million

    Book Value

    $510.61M
    FDMT annual book value is $510.61 million

    Retained Earnings

    -$576.20M
    FDMT annual retained earnings is -$576.20 million

    Working Capital

    $405.78M
    FDMT annual working capital is $405.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$134.59M
    FDMT annual cash from operations is -$134.59 million

    Cash From Operations 1-Year Change

    -77.57%
    FDMT annual cash from operations is down -77.57% year-on-year

    Cash From Investing

    -$302.44M
    FDMT annual cash from investing is -$302.44 million

    Cash From Investing 1-Year Change

    -361.36%
    FDMT annual cash from investing is down -361.36% year-on-year

    Cash From Financing

    $337.25M
    FDMT annual cash from financing is $337.25 million

    Cash From Financing 1-Year Change

    +115.04%
    FDMT annual cash from financing is up +115.04% year-on-year

    CAPEX

    CAPEX

    $3.79M
    FDMT annual capital expenditures is $3.79 million

    CAPEX 1-Year Change

    +36.63%
    FDMT annual capital expenditures is up +36.63% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$138.37M
    FDMT annual free cash flow is -$138.37 million

    Free Cash Flow 1-Year Change

    -76.13%
    FDMT annual free cash flow is down -76.13% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -18.02K%
    FDMT annual gross profit margin is -18.02 thousand%

    Operating Margin

    -507.68K%
    FDMT annual operating profit margin is -507.68 thousand%

    Net Margin

    -434.78K%
    FDMT annual net profit margin is -434.78 thousand%

    ROA & ROE

    ROA

    -35.74%
    FDMT annual return on assets is -35.74%

    ROE

    -39.31%
    FDMT annual return on equity is -39.31%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    FDMT price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    FDMT price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.66
    FDMT price to book ratio is 1.66

    PB Ratio Sector Percentile

    47.17%
    FDMT price to book ratio is higher than 47.17% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    5094.55
    FDMT price to sales ratio is 5094.55

    PS Ratio Sector Percentile

    98.79%
    FDMT price to sales ratio is higher than 98.79% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $328.55M
    FDMT enterprise value is $328.55 million

    Enterprise Value Sector Percentile

    58.91%
    FDMT enterprise value is higher than 58.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.47
    FDMT EV/EBITDA is -1.47

    EV/EBITDA Sector Percentile

    42.7%
    FDMT EV/EBITDA is higher than 42.7% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    14.92
    FDMT annual current ratio is 14.92

    Quick Ratio

    14.92
    FDMT annual quick ratio is 14.92

    Leverage

    Debt To Equity

    0.00
    FDMT annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    FDMT annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    FDMT piotroski f-score is 4

    Altman Z-Score

    5.69
    FDMT altman z-score is 5.69

    Analyst ratings

    Recent major analysts updates

    Nov 11, 25 RBC Capital
    Outperform
    Nov 11, 25 Chardan Capital
    Buy
    Nov 11, 25 Barclays
    Overweight
    Oct 21, 25 RBC Capital
    Outperform
    Aug 12, 25 Roth Capital
    Buy
    Aug 12, 25 Chardan Capital
    Buy
    Aug 1, 25 Chardan Capital
    Buy
    Jul 3, 25 Chardan Capital
    Buy
    May 9, 25 Goldman Sachs
    Buy
    May 9, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with FDMT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for 4D Molecular Therapeutics, Inc.?
    • Does 4D Molecular Therapeutics, Inc. pay dividends?
    • What sector is 4D Molecular Therapeutics, Inc. in?
    • What industry is 4D Molecular Therapeutics, Inc. in?
    • What country is 4D Molecular Therapeutics, Inc. based in?
    • When did 4D Molecular Therapeutics, Inc. go public?
    • Is 4D Molecular Therapeutics, Inc. in the S&P 500?
    • Is 4D Molecular Therapeutics, Inc. in the NASDAQ 100?
    • Is 4D Molecular Therapeutics, Inc. in the Dow Jones?
    • When was 4D Molecular Therapeutics, Inc.'s last earnings report?
    • When does 4D Molecular Therapeutics, Inc. report earnings?

    What is the ticker symbol for 4D Molecular Therapeutics, Inc.?

    The ticker symbol for 4D Molecular Therapeutics, Inc. is NASDAQ:FDMT

    Does 4D Molecular Therapeutics, Inc. pay dividends?

    No, 4D Molecular Therapeutics, Inc. does not pay dividends

    What sector is 4D Molecular Therapeutics, Inc. in?

    4D Molecular Therapeutics, Inc. is in the Healthcare sector

    What industry is 4D Molecular Therapeutics, Inc. in?

    4D Molecular Therapeutics, Inc. is in the Biotechnology industry

    What country is 4D Molecular Therapeutics, Inc. based in?

    4D Molecular Therapeutics, Inc. is headquartered in United States

    When did 4D Molecular Therapeutics, Inc. go public?

    4D Molecular Therapeutics, Inc.'s initial public offering (IPO) was on December 11, 2020

    Is 4D Molecular Therapeutics, Inc. in the S&P 500?

    No, 4D Molecular Therapeutics, Inc. is not included in the S&P 500 index

    Is 4D Molecular Therapeutics, Inc. in the NASDAQ 100?

    No, 4D Molecular Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is 4D Molecular Therapeutics, Inc. in the Dow Jones?

    No, 4D Molecular Therapeutics, Inc. is not included in the Dow Jones index

    When was 4D Molecular Therapeutics, Inc.'s last earnings report?

    4D Molecular Therapeutics, Inc.'s most recent earnings report was on November 10, 2025

    When does 4D Molecular Therapeutics, Inc. report earnings?

    The next expected earnings date for 4D Molecular Therapeutics, Inc. is February 27, 2026
    On this page